Literature DB >> 19608018

Downregulation of T helper cell type 3 in patients with acute coronary syndrome.

Qing-wei Ji1, Min Guo, Jin-song Zheng, Xiao-bo Mao, Yu-dong Peng, Song-nan Li, Zhi-shan Liang, Zhi-yin Dai, Yi Mao, Qiu-tang Zeng.   

Abstract

BACKGROUND AND AIMS: There is an imbalance between Th1 and Th2 in the development and progression of atherosclerosis and in patients with acute coronary syndrome (ACS) including acute myocardial infarction (AMI) and unstable angina. T helper cell type 3 (Th3), which primarily secretes transforming growth factor beta-1 (TGF-beta1), has been shown to inhibit both Th1 and Th2 cells. The present study was designed to investigate whether Th3 cells are involved in plaque destabilization and the onset of ACS.
METHODS: Ninety one patients who underwent diagnostic catheterization were classified into four groups (AMI group, unstable angina group, stable angina group and chest pain syndrome group). The cell frequencies of Th1, Th2 and Th3 were detected using flow cytometry, and the concentrations of their related cytokines IFN-gamma, IL-4 and TGF-beta1 were studied by ELISA.
RESULTS: Apart from the imbalance between Th1 and Th2, results revealed a significant decrease in peripheral Th3 number and levels of TGF-beta1 in patients with ACS as compared with those in patients with stable angina and chest pain syndrome (p<0.01).
CONCLUSIONS: Downregulation of Th3 cells in patients with ACS may play a potential role in plaque destabilization and the onset of ACS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608018     DOI: 10.1016/j.arcmed.2009.04.002

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  21 in total

1.  Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice.

Authors:  Kai Meng; Qiutang Zeng; Qinghua Lu; Yingzhong Lin; Bangwei Wu; Kunwu Yu; Zhaoqiang Dong; Jianwei Zhang; Meng Chai; Yuyang Liu; Qingwei Ji; Yujie Zhou
Journal:  Mol Med       Date:  2015-02-09       Impact factor: 6.354

2.  Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome.

Authors:  Min Guo; Xiaobo Mao; Qingwei Ji; Mingjian Lang; Songnan Li; Yudong Peng; Wei Zhou; Bo Xiong; Qiutang Zeng
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

3.  CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.

Authors:  Yucheng Zhong; Xiang Wang; Qingwei Ji; Xiaobo Mao; Hongxia Tang; Guiwen Yi; Kai Meng; Xiaofang Yang; Qiutang Zeng
Journal:  J Clin Immunol       Date:  2012-05-03       Impact factor: 8.317

Review 4.  Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.

Authors:  Charlotte Lahoute; Olivier Herbin; Ziad Mallat; Alain Tedgui
Journal:  Nat Rev Cardiol       Date:  2011-04-19       Impact factor: 32.419

5.  Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression.

Authors:  Oana Herlea-Pana; Longbiao Yao; Janet Heuser-Baker; Qiongxin Wang; Qilong Wang; Constantin Georgescu; Ming-Hui Zou; Jana Barlic-Dicen
Journal:  Cardiovasc Res       Date:  2015-03-12       Impact factor: 10.787

6.  CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.

Authors:  Jie Li; Sara McArdle; Amin Gholami; Takayuki Kimura; Dennis Wolf; Teresa Gerhardt; Jacqueline Miller; Christian Weber; Klaus Ley
Journal:  Circ Res       Date:  2016-03-28       Impact factor: 17.367

Review 7.  Lymphocyte migration into atherosclerotic plaque.

Authors:  Jie Li; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-09       Impact factor: 8.311

Review 8.  Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.

Authors:  Andrew P Sage; Ziad Mallat
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739

Review 9.  The complex regulation of TGF-β in cardiovascular disease.

Authors:  Santiago Redondo; Jorge Navarro-Dorado; Marta Ramajo; Úrsula Medina; Teresa Tejerina
Journal:  Vasc Health Risk Manag       Date:  2012-09-13

10.  Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.

Authors:  Yingzhong Lin; Ying Huang; Zhengde Lu; Cheng Luo; Ying shi; Qiutang Zeng; Yifeng Cao; Lin Liu; Xiaoyan Wang; Qingwei Ji
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.